Yes, Delta 8 THC occupies a legally ambiguous space in South Africa, where its status hinges on interpretation of the Medicines and Related Substances Act 101 of 1965 and the Drugs and Drug Trafficking Act 140 of 1992. The South African Health Products Regulatory Authority (SAHPRA) has not explicitly legalized Delta 8 THC, but its psychoactive properties (derived from hemp) may fall under controlled substances if exceeding 0.001% THC, as per SAHPRA’s 2021 cannabinoid scheduling. Retailers exploit a regulatory loophole by selling Delta 8 THC products labeled “not for human consumption,” though enforcement remains inconsistent. The 2026 Cannabis for Private Purposes Bill may clarify its status, but until then, Delta 8 THC operates in a grey zone where legal risk correlates with THC concentration and marketing claims.
Key Regulations for Delta 8 THC in South Africa
- THC Threshold Enforcement: Products with Delta 8 THC exceeding 0.001% total THC are treated as Schedule 7 substances under SAHPRA, requiring pharmaceutical licensing. Local labs report frequent seizures of products mislabeled as “hemp-derived” but containing higher THC levels.
- Marketing Restrictions: Advertising Delta 8 THC as a psychoactive or therapeutic agent violates the Consumer Protection Act 68 of 2008 and SAHPRA’s 2022 guidelines on unregistered medicines. Social media promotions have triggered SAHPRA compliance notices.
- Licensing for Manufacture: Facilities producing Delta 8 THC must hold a Manufacturing License from SAHPRA, even for hemp-based extracts. The 2023 Cannabis Master Plan prioritizes licensing for compliant producers, with non-compliant operators facing fines up to R10 million or imprisonment.